Cargando…

Cabazitaxel in recurrent/metastatic squamous cell carcinoma of the head and neck: phase II UNICANCER trial ORL03

Treatments are limited after platinum Cetuximab or anti-PD1 failure for patients with recurrent/metastatic head and neck squamous cell carcinoma. Cabazitaxel has increased overall survival in hormone-refractory metastatic prostate cancer after failure of Docetaxel. Our aim was to detect a signal of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fayette, Jerome, Guigay, Joel, Tourneau, Christophe Le, Degardin, Marian, Peyrade, Frederic, Neidhardt, Eve-Marie, Sablin, Marie-Paule, Even, Caroline, Orlandini, Florence, Juzyna, Béata, Bellera, Carine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Clinical Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584293/ https://www.ncbi.nlm.nih.gov/pubmed/28881692 http://dx.doi.org/10.18632/oncotarget.15901

Ejemplares similares

Les urgences infectieuses ORL
por: Sereme, Moustapha, et al.
Publicado: (2016)

A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study
por: Diéras, Véronique, et al.
Publicado: (2016)

Anesthesia for ORL surgery in children
por: Becke, Karin
Publicado: (2014)

O.R.L. : revisión y actualización
por: Montgomery, P.Q
Publicado: (1994)

COVID-19 et chirurgie ORL()
por: Couloigner, V., et al.
Publicado: (2020)

Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Question of Belief
por: Karabajakian, Andy, et al.
Publicado: (2018)

The influence of endotoxin on the expression of the ORL-1 receptor
por: Stamer, UM, et al.
Publicado: (2001)

Preclinical profile of cabazitaxel
por: Vrignaud, Patricia, et al.
Publicado: (2014)

The Antioxidant Activity and Induction of Apoptotic Cell Death by Musa paradisiaca and Trigona sp. Honey Jelly in ORL115 and ORL188 Cells
por: Anuar, Mohd Nur Nasyriq, et al.
Publicado: (2023)

Some considerations concerning cochlear implantation in IFACF-ORL
por: Hainarosie, M, et al.
Publicado: (2014)

Les infections virales de la sphère ORL
por: Berthélémy, Stéphane
Publicado: (2010)

Observational, prospective, phase 4 study in patients with first‐line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with cetuximab and platinum‐based therapy: DIRECT
por: Guigay, Joël, et al.
Publicado: (2021)

Questionnements éthiques liés au Covid-19 en ORL()
por: Simon, F.
Publicado: (2020)

Foreign Bodies in the Oesophagus: The Experience of the Buenos Aires Paediatric ORL Clinic
por: Chinski, Alberto, et al.
Publicado: (2010)

Last days in the old radiation laboratory (ORL), Berkeley, California, 1954
por: Benson, Andrew A.
Publicado: (2010)

Les corps étrangers en ORL: expérience de dix ans
por: Hssaine, Khaoula, et al.
Publicado: (2015)

UNICANCER: French prospective cohort study of treatment-related chronic toxicity in women with localised breast cancer (CANTO)
por: Vaz-Luis, Ines, et al.
Publicado: (2019)

Phase I dose-escalation study of F14512, a polyamine-vectorized topoisomerase II inhibitor, in patients with platinum-refractory or resistant ovarian cancer
por: Leary, Alexandra, et al.
Publicado: (2018)

Therapeutic Effect of Cabazitaxel and Blood-Brain Barrier opening in a Patient-Derived Glioblastoma Model
por: Sulheim, Einar, et al.
Publicado: (2019)

Feasibility of cabazitaxel in octogenarian prostate cancer patients
por: Tralongo, Paolo, et al.
Publicado: (2023)

Diagnóstico y tratamiento de la patología ORL en atención primaria /
Publicado: (2000)

“OCTOPUS”: An Intelligent Tool for Assisted Multidisciplinary ORL Oncology Meetings—Preliminary Study
por: Ouattassi, Naouar, et al.
Publicado: (2023)

Carboplatin in combination with weekly Paclitaxel as first-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma unfit to EXTREME schedule
por: Pêtre, Adeline, et al.
Publicado: (2018)

Clinical and histological characteristics, and management of melanoma in French Guiana, 2007–2018
por: Broly, Marine, et al.
Publicado: (2020)

Téléconsultation en ORL : enquête de satisfaction en période pandémique COVID-19
por: Fieux, M., et al.
Publicado: (2020)

Optimizing the Management of the Main Acute Infections in Pediatric ORL: Tonsillitis, Sinusitis, Otitis media
por: Sih, Tania Maria, et al.
Publicado: (2015)

Critical appraisal of cabazitaxel in the management of advanced prostate cancer
por: Pal, Sumanta Kumar, et al.
Publicado: (2010)

Population pharmacokinetics of cabazitaxel in patients with advanced solid tumors
por: Ferron, Géraldine M., et al.
Publicado: (2013)

A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients
por: Becher, François, et al.
Publicado: (2017)

Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER)
por: Tougeron, David, et al.
Publicado: (2021)

Apoptosis-Inducing Effect of Three Medicinal Plants on Oral Cancer Cells KB and ORL-48
por: Majid, Mohd Zabidi, et al.
Publicado: (2014)

Conseils de bonnes pratiques : consultation d’ORL en contexte épidémique COVID-19()
por: Lescanne, E., et al.
Publicado: (2020)

The design of a user-centred m-health application for caregivers of children undergoing ORL surgery
por: Dobrina, R, et al.
Publicado: (2022)

Management of digestive cancers during the COVID-19 second wave: A French intergroup point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR)
por: Tougeron, David, et al.
Publicado: (2021)

Clinical Development of Cabazitaxel for the Treatment of Castration-Resistant Prostate Cancer
por: Tsao, Che-Kai, et al.
Publicado: (2011)

Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer
por: Di Lorenzo, Giuseppe, et al.
Publicado: (2016)

Cabazitaxel-Loaded Nanocarriers for Cancer Therapy with Reduced Side Effects
por: Kommineni, Nagavendra, et al.
Publicado: (2019)

Cabazitaxel Induced Thrombotic Microangiopathy in a Patient with Prostate Cancer
por: Nlandu, Yannick, et al.
Publicado: (2019)

TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer
por: Sekino, Yohei, et al.
Publicado: (2019)

Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer
por: Pobel, Cedric, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1qs6mdariur900shigsvjcm517